A/S Novo Insider Trading Transactions
Get free email notifications about insider trading for A/S Novo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).
Latest Insider Trading Transactions of A/S Novo
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | RPHM | Reneo Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 12,367,054 | 0 | 0 | |
Apr 14 2021 | RPHM | Reneo Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 666,666 | 9,999,990 | 3,430,377 | 2.8 M to 3.4 M (+24.12 %) |
Apr 14 2021 | RPHM | Reneo Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,763,711 | 0 | 2,763,711 | 0 to 2.8 M |
Mar 31 2021 | EWTX | Edgewise Therapeut ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 650,328 | 0 | 0 | |
Mar 31 2021 | EWTX | Edgewise Therapeut ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,952,439 | 0 | 0 | |
Mar 31 2021 | EWTX | Edgewise Therapeut ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 2,359,440 | 0 | 0 | |
Mar 31 2021 | EWTX | Edgewise Therapeut ... | Novo Holdings A/S | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 5,587,207 | 5 M to 5.6 M (+12.60 %) |
Mar 31 2021 | EWTX | Edgewise Therapeut ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 4,962,207 | 0 | 4,962,207 | 0 to 5 M |
Mar 03 2021 | INGN | Inogen Inc | Novo Holdings A/S | 10% Owner | Sell | S | 49.00 | 790,000 | 38,710,000 | 2,759,320 | 3.5 M to 2.8 M (-22.26 %) |
Feb 19 2021 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Sell | S | 10.58 | 500,000 | 5,290,000 | 2,459,021 | 3 M to 2.5 M (-16.90 %) |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 458,337 | 0 | 0 | |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 421,670 | 0 | 0 | |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 2,050,758 | 0 | 0 | |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,096,323 | 0 | 0 | |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Buy | P | 20.00 | 400,000 | 8,000,000 | 4,503,991 | 4.1 M to 4.5 M (+9.75 %) |
Feb 11 2021 | BOLT | Bolt Biotherapeuti ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 4,027,088 | 0 | 4,103,991 | 76.9 K to 4.1 M (+5,236.58 %) |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 737,071 | 0 | 0 | |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Buy | P | 18.00 | 150,000 | 2,700,000 | 887,071 | 737.1 K to 887.1 K (+20.35 %) |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 737,071 | 0 | 737,071 | 0 to 737.1 K |
Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 241,219 | 0 | 0 | |
Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 563,851 | 0 | 0 | |
Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,609,493 | 0 | 0 | |
Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 2,614,563 | 2.4 M to 2.6 M (+8.28 %) |
Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,414,563 | 0 | 2,414,563 | 0 to 2.4 M |
Oct 21 2020 | PRAX | Praxis Precision M ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 352,734 | 0 | 0 | |
Oct 21 2020 | PRAX | Praxis Precision M ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 171,410 | 0 | 0 | |
Oct 21 2020 | PRAX | Praxis Precision M ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 551,794 | 0 | 0 | |
Oct 21 2020 | PRAX | Praxis Precision M ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 4,150,000 | 0 | 0 | |
Oct 21 2020 | PRAX | Praxis Precision M ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,442,080 | 0 | 2,442,080 | 0 to 2.4 M |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 21,000,000 | 0 | 0 | |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 4,989,336 | 4.7 M to 5 M (+5.28 %) |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 4,739,336 | 0 | 4,739,336 | 0 to 4.7 M |
Aug 25 2020 | HRMY | Harmony Bioscience ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,860,107 | 0 | 0 | |
Aug 25 2020 | HRMY | Harmony Bioscience ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 25,000,000 | 0 | 0 | |
Aug 25 2020 | HRMY | Harmony Bioscience ... | Novo Holdings A/S | 10% Owner | Buy | P | 24.00 | 132,503 | 3,180,072 | 4,409,803 | 4.3 M to 4.4 M (+3.10 %) |
Aug 25 2020 | HRMY | Harmony Bioscience ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 4,277,300 | 0 | 4,277,300 | 0 to 4.3 M |
Aug 13 2020 | CMPI | Checkmate Pharmace ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 12,487,512 | 0 | 0 | |
Aug 13 2020 | CMPI | Checkmate Pharmace ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 500,000 | 7,500,000 | 2,170,100 | 1.7 M to 2.2 M (+29.94 %) |
Aug 13 2020 | CMPI | Checkmate Pharmace ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,670,100 | 0 | 1,670,100 | 0 to 1.7 M |
Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,398,600 | 0 | 0 | |
Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,569,379 | 2.2 M to 2.6 M (+17.09 %) |
Jul 29 2020 | INZY | Inozyme Pharma, In ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,194,379 | 0 | 2,194,379 | 0 to 2.2 M |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,712,811 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 525,499 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Buy | P | 18.00 | 555,555 | 9,999,990 | 2,793,865 | 2.2 M to 2.8 M (+24.82 %) |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,238,310 | 0 | 2,238,310 | 0 to 2.2 M |
Jul 09 2020 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.37 | 741,440 | 3,985,166 | 1,389,498 | 2.1 M to 1.4 M (-34.79 %) |
Jul 09 2020 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.25 | 796,622 | 4,183,381 | 2,130,938 | 2.9 M to 2.1 M (-27.21 %) |
Nov 27 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Sell | S | 16.00 | 240,000 | 3,840,000 | 2,434,470 | 2.7 M to 2.4 M (-8.97 %) |
Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 2,709,659 | 0 | 0 | |
Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 12.00 | 500,000 | 6,000,000 | 3,409,021 | 2.9 M to 3.4 M (+17.19 %) |
Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 535,869 | 0 | 2,909,021 | 2.4 M to 2.9 M (+22.58 %) |
Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,373,152 | 0 | 2,373,152 | 0 to 2.4 M |
Jul 25 2019 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 4.00 | 1,400,000 | 5,600,000 | 2,927,560 | 4.3 M to 2.9 M (-32.35 %) |
Jul 25 2019 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.01 | 53,240 | 266,711 | 4,327,560 | 4.4 M to 4.3 M (-1.22 %) |
Jul 25 2019 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.32 | 39,716 | 211,134 | 4,380,800 | 4.4 M to 4.4 M (-0.90 %) |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,870,147 | 0 | 0 | |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 575,000 | 8,625,000 | 2,445,147 | 1.9 M to 2.4 M (+30.75 %) |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,870,147 | 0 | 1,870,147 | 0 to 1.9 M |
Jul 01 2019 | MORF | Morphic Holding, I ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,978,779 | 0 | 0 | |
Jul 01 2019 | MORF | Morphic Holding, I ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 666,667 | 10,000,005 | 2,645,446 | 2 M to 2.6 M (+33.69 %) |
Jul 01 2019 | MORF | Morphic Holding, I ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,978,779 | 0 | 1,978,779 | 0 to 2 M |
May 14 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Option Exercise | M | 0.00 | 964,089 | 0 | 0 | |
May 14 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Option Exercise | M | 0.00 | 1,377,048 | 0 | 0 | |
May 14 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 333,333 | 4,999,995 | 2,674,470 | 2.3 M to 2.7 M (+14.24 %) |
May 14 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Buy | M | 0.00 | 964,089 | 0 | 2,341,137 | 1.4 M to 2.3 M (+70.01 %) |
May 14 2019 | MIST | Milestone Pharmace ... | Novo Holdings A/S | 10% Owner | Buy | M | 0.00 | 1,377,048 | 0 | 1,377,048 | 0 to 1.4 M |
Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 14,237,288 | 0 | 0 | |
Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 1,089,835 | 16,347,525 | 2,181,843 | 1.1 M to 2.2 M (+99.80 %) |
Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,092,008 | 0 | 1,092,008 | 0 to 1.1 M |
Mar 13 2018 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Buy | P | 8.50 | 1,176,470 | 9,999,995 | 4,420,516 | 3.2 M to 4.4 M (+36.27 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 8.50 | 1,726,000 | 14,671,000 | 0 | 1.7 M to 0 (-100.00 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 10.02 | 481 | 4,820 | 1,726,000 | 1.7 M to 1.7 M (-0.03 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 10.21 | 35,519 | 362,763 | 1,726,481 | 1.8 M to 1.7 M (-2.02 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 15.36 | 75,123 | 1,153,889 | 1,762,000 | 1.8 M to 1.8 M (-4.09 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 14.07 | 57,580 | 809,961 | 1,837,123 | 1.9 M to 1.8 M (-3.04 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 13.39 | 61,044 | 817,330 | 1,894,703 | 2 M to 1.9 M (-3.12 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 12.32 | 165,199 | 2,036,012 | 1,955,747 | 2.1 M to 2 M (-7.79 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 11.18 | 190,981 | 2,134,404 | 2,120,946 | 2.3 M to 2.1 M (-8.26 %) |
Oct 12 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 10.36 | 413,356 | 4,281,004 | 2,311,927 | 2.7 M to 2.3 M (-15.17 %) |
Sep 15 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 8.00 | 3 | 24 | 2,725,280 | 2.7 M to 2.7 M (0.00 %) |
Sep 15 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 7.00 | 140,744 | 985,841 | 2,725,283 | 2.9 M to 2.7 M (-4.91 %) |
Sep 15 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 8.05 | 10,000 | 80,500 | 2,866,027 | 2.9 M to 2.9 M (-0.35 %) |
Sep 15 2017 | KALV | KalVista Pharmaceu ... | Novo Holdings A/S | 10% Owner | Sell | S | 8.02 | 25,900 | 207,614 | 2,876,027 | 2.9 M to 2.9 M (-0.89 %) |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 1.75 | 720,214 | 1,260,591 | 0 | 720.2 K to 0 (-100.00 %) |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 1.91 | 382,437 | 729,919 | 720,214 | 1.1 M to 720.2 K (-34.68 %) |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.02 | 47,162 | 95,475 | 1,102,651 | 1.1 M to 1.1 M (-4.10 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.01 | 12,641 | 25,412 | 1,199,599 | 1.2 M to 1.2 M (-1.04 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.02 | 12,845 | 25,976 | 1,212,240 | 1.2 M to 1.2 M (-1.05 %) |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAG ... | Novo Holdings A/S | 10% Owner | Sell | S | 2.10 | 55,100 | 115,600 | 1,225,085 | 1.3 M to 1.2 M (-4.30 %) |
Aug 21 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.10 | 356,300 | 7,518,251 | 1,936,604 | 2.3 M to 1.9 M (-15.54 %) |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.00 | 143,428 | 3,011,988 | 2,292,904 | 2.4 M to 2.3 M (-5.89 %) |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.79 | 35,172 | 766,493 | 2,436,332 | 2.5 M to 2.4 M (-1.42 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.92 | 1,023 | 23,443 | 2,471,504 | 2.5 M to 2.5 M (-0.04 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.10 | 480,000 | 10,128,000 | 2,472,527 | 3 M to 2.5 M (-16.26 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.00 | 10,271 | 225,963 | 2,952,527 | 3 M to 3 M (-0.35 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.01 | 21,451 | 472,192 | 2,962,798 | 3 M to 3 M (-0.72 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 23.87 | 25,700 | 613,485 | 2,984,249 | 3 M to 3 M (-0.85 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 23.87 | 23,555 | 562,270 | 3,009,949 | 3 M to 3 M (-0.78 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.84 | 8,426 | 57,643 | 1,301,842 | 1.3 M to 1.3 M (-0.64 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.96 | 24,504 | 170,585 | 1,310,268 | 1.3 M to 1.3 M (-1.84 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.83 | 17,200 | 117,538 | 1,334,772 | 1.4 M to 1.3 M (-1.27 %) |
Jun 27 2017 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Buy | P | 10.95 | 20,000 | 219,000 | 3,244,046 | 3.2 M to 3.2 M (+0.62 %) |
Jun 23 2017 | RETA | REATA PHARMACEUTIC ... | Novo Holdings A/S | 10% Owner | Option Exercise | S | 0.00 | 1,200,000 | 0 | 1,201,969 | |
Jun 14 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 25.03 | 49,611 | 1,241,853 | 592,794 | 642.4 K to 592.8 K (-7.72 %) |
Jun 14 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 25.47 | 11,389 | 290,073 | 642,405 | 653.8 K to 642.4 K (-1.74 %) |
Jun 12 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 25.28 | 90,303 | 2,282,824 | 653,794 | 744.1 K to 653.8 K (-12.14 %) |
Jun 12 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 25.89 | 2,200 | 56,955 | 744,097 | 746.3 K to 744.1 K (-0.29 %) |
Jun 12 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 26.00 | 130,000 | 3,380,000 | 746,297 | 876.3 K to 746.3 K (-14.84 %) |
Jun 07 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 28.04 | 2,000 | 56,079 | 876,297 | 878.3 K to 876.3 K (-0.23 %) |
Jun 07 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 28.09 | 64,170 | 1,802,490 | 878,297 | 942.5 K to 878.3 K (-6.81 %) |
Jun 07 2017 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Sell | S | 28.67 | 23,327 | 668,825 | 942,467 | 965.8 K to 942.5 K (-2.42 %) |
May 11 2017 | LPTN | Apollo Endosurgery ... | Novo A/S | 10% Owner | Sell | S | 5.62 | 103,500 | 582,094 | 1,351,972 | 1.5 M to 1.4 M (-7.11 %) |
May 11 2017 | LPTN | Apollo Endosurgery ... | Novo A/S | 10% Owner | Sell | S | 5.74 | 1,500 | 8,609 | 1,455,472 | 1.5 M to 1.5 M (-0.10 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | X | 4.55 | 117,235 | 533,419 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 673,454 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 312,986 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 486,820 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,428,571 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | P | 15.00 | 50,000 | 750,000 | 3,033,504 | 3 M to 3 M (+1.68 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | X | 0.00 | 81,673 | 0 | 2,983,504 | 2.9 M to 3 M (+2.81 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 673,454 | 0 | 2,901,831 | 2.2 M to 2.9 M (+30.22 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 312,986 | 0 | 2,228,377 | 1.9 M to 2.2 M (+16.34 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 486,820 | 0 | 1,915,391 | 1.4 M to 1.9 M (+34.08 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,428,571 | 0 | 1,428,571 | 0 to 1.4 M |
Dec 16 2016 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | S | 4.72 | 1,405,487 | 6,636,007 | 0 | 1.4 M to 0 (-100.00 %) |
Dec 16 2016 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | S | 4.97 | 2,205,000 | 10,962,378 | 1,405,487 | 3.6 M to 1.4 M (-61.07 %) |
Nov 02 2016 | RARX | Ra Pharmaceuticals ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 860,438 | 0 | 0 | |
Nov 02 2016 | RARX | Ra Pharmaceuticals ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 924,970 | 0 | 0 | |
Nov 02 2016 | RARX | Ra Pharmaceuticals ... | Novo A/S | 10% Owner | Buy | P | 13.00 | 246,154 | 3,200,002 | 2,031,562 | 1.8 M to 2 M (+13.79 %) |
Nov 02 2016 | RARX | Ra Pharmaceuticals ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 860,438 | 0 | 1,785,408 | 925 K to 1.8 M (+93.02 %) |
Nov 02 2016 | RARX | Ra Pharmaceuticals ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 924,970 | 0 | 924,970 | 0 to 925 K |
Oct 26 2016 | IRTC | iRhythm Technologi ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 2,007,449 | 0 | 0 | |
Oct 26 2016 | IRTC | iRhythm Technologi ... | Novo A/S | 10% Owner | Buy | P | 17.00 | 100,000 | 1,700,000 | 2,124,448 | 2 M to 2.1 M (+4.94 %) |
Oct 26 2016 | IRTC | iRhythm Technologi ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 2,007,449 | 0 | 2,024,448 | 17 K to 2 M (+11,809.22 %) |
Sep 13 2016 | CLCD | CoLucid Pharmaceut ... | Novo A/S | 10% Owner | Buy | P | 20.00 | 100,000 | 2,000,000 | 3,156,563 | 3.1 M to 3.2 M (+3.27 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 11.88 | 29,884 | 354,944 | 1,875,905 | 1.9 M to 1.9 M (-1.57 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.12 | 8,752 | 106,072 | 1,905,789 | 1.9 M to 1.9 M (-0.46 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.19 | 20,431 | 249,101 | 1,914,541 | 1.9 M to 1.9 M (-1.06 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.03 | 21,869 | 263,150 | 1,934,972 | 2 M to 1.9 M (-1.12 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.20 | 59,850 | 730,272 | 1,956,841 | 2 M to 2 M (-2.97 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.57 | 10,400 | 130,709 | 2,016,691 | 2 M to 2 M (-0.51 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.58 | 27,133 | 341,368 | 2,027,091 | 2.1 M to 2 M (-1.32 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.63 | 16,068 | 202,947 | 2,054,224 | 2.1 M to 2.1 M (-0.78 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 14.28 | 2,730 | 38,975 | 2,070,292 | 2.1 M to 2.1 M (-0.13 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 13.77 | 20,883 | 287,651 | 2,073,022 | 2.1 M to 2.1 M (-1.00 %) |